Physician

Mark Roger Olsen, M.D.

According to 2025 Medicare claims, Mark Olsen, M.D. (NPI: 1356382592) practices medical oncology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236.

Olsen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,068 traditional Medicare patients, billed 214,991 HCPCS/CPT codes, and received $3,605,887 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 1,054 prescription claims across 199 beneficiaries totaling $2,508,840 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 72 claims. Open Payments data shows 31 records totaling $10,830. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $5,077 to $1,104.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	948	187,661	$2,113,031
2016	1,199	270,960	$3,414,695
2017	1,210	229,613	$3,154,140
2018	1,087	181,681	$2,697,845
2019	1,197	209,408	$3,500,735
2020	1,242	222,412	$3,895,359
2021	1,299	205,396	$3,567,259
2022	1,122	190,580	$3,256,415
2023	1,108	225,478	$3,485,208
2024	1,068	214,991	$3,605,887

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	196	1,044	$1,355,553
2016	238	1,251	$2,049,762
2017	249	1,394	$2,696,289
2018	220	1,355	$3,075,618
2019	215	1,067	$1,906,736
2020	229	1,258	$2,389,953
2021	192	1,202	$2,823,237
2022	194	1,047	$2,958,163
2023	222	1,124	$2,520,469
2024	199	1,054	$2,508,840

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	33	218	$128,896
2016	72	269	$100,931
2017	34	201	$54,151
2018	12	78	$15,180
2019	N/R	51	$8,135
2020	N/R	29	$3,258
2021	N/R	N/R	N/R
2022	N/R	32	$1,567
2023	N/R	72	$15,523
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	361	1,140	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	374	1,186	$8
83735	Magnesium level	359	1,137	$6
83615	Lactate dehydrogenase (enzyme) level	359	1,138	$6
84100	Phosphate level	359	1,137	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	41	1,148	$724,738
Imbruvica	Ibrutinib	21	614	$268,598
Ibrance	Palbociclib	16	448	$253,668
Calquence	Acalabrutinib Maleate	19	558	$220,746
Xtandi	Enzalutamide	19	570	$192,988

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$544	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$10,287	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Roger Olsen, M.D.?

Tedicare shows public-source Medicare data for Mark Roger Olsen, M.D. (NPI 1356382592), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Roger Olsen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Roger Olsen, M.D.?

Mark Roger Olsen, M.D. is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Mark Roger Olsen, M.D. have Open Payments data?

Mark Roger Olsen, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.